Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance

Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance

Abstract Background Despite new and better treatments for juvenile dermatomyositis (JDM), not all patients with moderate severity disease respond adequately to first-line therapy. Those with refractory disease remain at higher risk for disease and glucocorticoid-related complications. Biologic disea...

Full description

Bibliographic Details
Main Authors: Matthew A. Sherman, Hanna Kim, Katelyn Banschbach, Amanda Brown, Harry L. Gewanter, Bianca Lang, Megan Perron, Angela Byun Robinson, Jacob Spitznagle, Cory Stingl, Grant Syverson, Heather O. Tory, Charles H. Spencer, Stacey E. Tarvin
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Juvenile dermatomyositis
Dmards
Biologics
Online Access:https://doi.org/10.1186/s12969-022-00785-5

Internet

https://doi.org/10.1186/s12969-022-00785-5

Similar Items